Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on June 04, 2026, sold 25,000 shares in Krystal Biotech (KRYS) for $7,702,984. Following the Form 4 filing with the SEC, Krishnan has control over a total of 1,590,253 common shares of the company, with 1,450,253 shares held directly and 140,000 controlled indirectly.
SEC Filing: